Ship Healthcare (3360) Q2 2026 earnings summary

Executive summary

• Net sales for the six months ended September 30, 2025, rose 7.5% year-over-year to ¥333.4 billion, with operating profit up 5.6% to ¥8.18 billion and ordinary profit up 3.7% to ¥8.72 billion, while profit attributable to owners of parent declined 1.9% to ¥5.43 billion, impacted by non-recurring M&A advisory fees.

• All business segments reported year-over-year sales growth, with notable integration and efficiency gains.

• Performance generally aligned with initial plans, marking the first year of the medium-term management plan “SHIP VISION 2030,” focusing on new business creation, reorganization, and growth field expansion.

Financial highlights

• Net sales: ¥333.4 billion (+7.5% YoY); Operating profit: ¥8.18 billion (+5.6% YoY); Ordinary profit: ¥8.72 billion (+3.7% YoY).

• Gross profit increased to ¥29,318 million from ¥28,007 million year-over-year.

• Profit attributable to owners of parent: ¥5.43 billion (-1.9% YoY); Net income per share: ¥160.34; Comprehensive income rose 21.7% YoY to ¥6,353 million.

• Dividend per share: 58 yen (36.2% payout ratio), with a plan to increase to 60 yen (36.0% payout ratio) for the full year; dividend forecast for FY ending March 2026 is ¥60.00 per share.

• Cash and cash equivalents at period-end were ¥71,206 million, down ¥3,655 million from the previous fiscal year-end.

Outlook and guidance

• Full-year net sales forecast at ¥700 billion and operating profit at ¥26 billion; ordinary profit of ¥26.5 billion and profit attributable to owners of parent of ¥15.5 billion.

• Continued focus on business integration, operational efficiency, and expansion into new domains such as Well-Being.

• New logistics center in Tokyo to begin operation in December 2025, supporting future growth.

• No changes to previously announced financial forecasts.